Tony Lahoutte Selected Research

Tony Lahoutte Research Topics

Disease

42	Neoplasms (Cancer) 01/2022 - 09/2002
12	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2002
9	Inflammation (Inflammations) 10/2016 - 09/2003
6	Carcinoma (Carcinomatosis) 11/2019 - 05/2008
4	Neoplasm Metastasis (Metastasis) 04/2020 - 12/2003
4	Atherosclerotic Plaque (Atheroma) 01/2018 - 10/2014
4	Rhabdomyosarcoma 04/2010 - 09/2002
4	Aortic Valve Insufficiency (Aortic Regurgitation) 06/2009 - 09/2007
3	Multiple Myeloma 01/2022 - 07/2014
3	Amyloidosis 01/2017 - 12/2016
3	Heart Valve Diseases (Valvular Heart Disease) 09/2009 - 09/2007
2	Experimental Arthritis 10/2016 - 05/2013
2	Arthritis (Polyarthritis) 10/2016 - 04/2014
2	Rheumatoid Arthritis 05/2014 - 05/2013
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2014 - 05/2009
2	Infarction (Infarctions) 12/2011 - 01/2005
2	Mitral Valve Insufficiency (Mitral Regurgitation) 09/2009 - 09/2007
2	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 04/2009 - 09/2007
1	Brain Neoplasms (Brain Tumor) 08/2019
1	Atherosclerosis 01/2018
1	Hemorrhage 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2017
1	Lymphoma (Lymphomas) 12/2017
1	Neuroblastoma 11/2017
1	Hypercholesterolemia 01/2017
1	Amyloid Plaque 12/2016
1	Type II Lattice Corneal Dystrophy 12/2016
1	Hepatitis 02/2015
1	Prostatic Neoplasms (Prostate Cancer) 05/2014
1	Chronic Renal Insufficiency 11/2013
1	Pancreatitis 09/2013

Drug/Important Bio-Agent (IBA)

28	Single-Domain AntibodiesIBA 01/2022 - 05/2008
11	Radioisotopes (Radionuclides)IBA 01/2022 - 04/2010
8	Mannose ReceptorIBA 01/2021 - 08/2012
6	ErbB Receptors (EGF Receptor)IBA 01/2021 - 05/2008
6	Pharmaceutical PreparationsIBA 08/2019 - 09/2007
6	Proteins (Proteins, Gene)FDA Link 11/2014 - 07/2010
5	human ERBB2 proteinIBA 01/2021 - 07/2011
5	Trastuzumab (Herceptin)FDA Link 04/2020 - 01/2013
5	Amino Acids FDA Link 09/2013 - 09/2002
4	Biomarkers (Surrogate Marker)IBA 07/2021 - 10/2014
4	N-succinimidyl 4-guanidinomethyl-3-iodobenzoateIBA 04/2020 - 04/2014
4	AntibodiesIBA 11/2019 - 01/2013
4	AntigensIBA 11/2019 - 05/2010
3	Chelating AgentsIBA 04/2021 - 03/2012
3	Monoclonal AntibodiesIBA 04/2020 - 11/2014
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2017 - 04/2014
3	GelsolinIBA 01/2017 - 12/2016
3	Phenylalanine (L-Phenylalanine)FDA Link 04/2010 - 09/2002
2	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 09/2021 - 05/2013
2	Pentetic Acid (DTPA)FDA LinkGeneric 04/2020 - 01/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2019 - 02/2011
2	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2018
2	Astatine-211IBA 01/2019 - 01/2016
2	oxidized low density lipoproteinIBA 01/2017 - 10/2014
2	Amyloid (Amyloid Fibrils)IBA 01/2017 - 01/2017
2	Firefly LuciferasesIBA 10/2011 - 04/2010
2	Serotonin (5 Hydroxytryptamine)IBA 09/2009 - 09/2007
2	Pergolide (Permax)FDA Link 06/2009 - 09/2007
2	Tyrosine (L-Tyrosine)FDA Link 07/2007 - 08/2006
2	2-iodotyrosineIBA 07/2007 - 09/2004
1	ParaproteinsIBA 01/2022
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 04/2020
1	Surface Antigens (Surface Antigen)IBA 11/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2019
1	Biological ProductsIBA 08/2019
1	Rituximab (Mabthera)FDA Link 12/2017
1	Insulin (Novolin)FDA Link 11/2017
1	LDL CholesterolIBA 01/2017
1	Ezetimibe (Zetia)FDA Link 01/2017
1	CholesterolIBA 01/2017
1	Complement Receptors (Complement Receptor)IBA 10/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2016
1	Bismuth-213IBA 01/2016
1	CC ChemokinesIBA 08/2015
1	Concanavalin AIBA 02/2015
1	LectinsIBA 10/2014
1	Apolipoproteins E (ApoE)IBA 10/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2014
1	CytokinesIBA 07/2014
1	Tumor Biomarkers (Tumor Markers)IBA 05/2014
1	Indium-111IBA 05/2014
1	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2014
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2014
1	LigandsIBA 04/2014
1	Purinergic P2X7 ReceptorsIBA 04/2014
1	PhosphatidylserinesIBA 04/2014
1	Chemokine ReceptorsIBA 04/2014
1	E-SelectinIBA 04/2014
1	IntegrinsIBA 04/2014
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2014
1	Matrix Metalloproteinases (MMPs)IBA 04/2014
1	succinylated gelatinIBA 01/2014
1	N- (2- chlorophenylpropyl)- 1- (3- methoxyphenyl)ethylamineIBA 11/2013

Therapy/Procedure

24	Therapeutics 01/2022 - 01/2005
5	Precision Medicine 01/2022 - 12/2014
3	Radioimmunotherapy 11/2019 - 03/2012
3	Intravenous Injections 08/2012 - 09/2002
1	Combination Drug Therapy (Combination Chemotherapy) 01/2018